Marina Almató Bellavista

Marina Almató Bellavista is an accomplished research associate currently working at Roche since February 2021, focusing on genomics and transcriptomics within the Developmental Systems and Computational Biology Group. Marina's expertise includes the automation of protocols and high-throughput drug screening, particularly in brain organoid models. Previous roles include developing evidence-generation strategies for HCC biomarkers in clinical development and medical affairs at Roche, as well as a position at Neurix SA as an associate biotechnology engineer. Additional experience spans clinical research assistance at HUG - Hopitaux Universitaires de Genève and internships in Alzheimer's disease research and computational neuroimaging. Marina holds a Master's degree in Neuroscience from the University of Geneva, a CAS in Clinical Research from the University of Basel, and a Bachelor's degree in Biotechnology from Universitat de Girona.